MedTrace Logo

Intestinal Health and Blood Lipid Adjustment

NCT02116101 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2014-04-16

No results posted yet for this study

Summary

This was a randomized, double-blind, single-center, placebo-controlled, two-arm study. The objectives of this study were to evaluate the effect of Momchilovtsi yogurt on:

1. Improving intestinal digestion and bowl movement;
2. Adjusting blood total Cholesterol and Triglycerides levels;
3. Adjusting microbiological flora (Clostridium perfringens bacteria, Lactobacillus and Bifidobacterium) in gastrointestinal tract;
4. Adjusting short chain fatty acids (acetic acid, propionic acid, butyric acid) in in gastrointestinal tract.

Conditions

Interventions

DIETARY_SUPPLEMENT

Bright Momchilovtsi Yogurt

Oral consumption of Bright Momchilovtis Yogurt containing 1×106cfu/g prebiotics including Lactobacillus bulgaricus and Streptococcus thermophilus Dosage: 110g at a time, twice per day at 10 am and 4 pm. Duration: 7 weeks (March 10, 2013 - April 27, 2013) The active study product has similar package and taste as the placebo.

DIETARY_SUPPLEMENT

Bright Dairy Beverage

Oral consumption of Bright Dairy Beverage Dosage: 110g at a time, twice per day at 10 am and 4 pm. Duration: 7 weeks (March 10, 2013 - April 27, 2013) The active study product has similar package and taste as the placebo.

Sponsors & Collaborators

  • Bright Dairy & Food Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Donglian Cai, MD · Department of Nutrition, The Second Military Medical University Affilated Changhai Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-04-30
Completion
2013-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02116101 on ClinicalTrials.gov